LEADER 01278nam  2200361 a 450 
001 9910695172003321
005 20060620160914.0
035   $a(CKB)5470000002367008
035   $a(OCoLC)70144766
035   $a(EXLCZ)995470000002367008
100   $a20060620d2006      ua             0
101 0 $aeng
135   $aurmn|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety$b[electronic resource] $eimprovement needed in FDA's postmarket decision-making and oversight process : report to congressional requesters
210  1$a[Washington, D.C.] :$cU.S. Government Accountability Office,$d[2006]
215   $aii, 62 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on June 19, 2006).
300   $a"March 2006."
300   $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
300   $a"GAO-06-402."
320   $aIncludes bibliographical references.
517   $aDrug safety 
606   $aDrugs$zUnited States$xSafety measures
615  0$aDrugs$xSafety measures.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695172003321
996   $aDrug safety$92379886
997   $aUNINA